Patient and Provider Acceptability of a Patient Preauthorized Concealed Opioid Reduction.

ABSTRACT:

Objective

Limited research of how to best taper opioids brings about an ethical and clinical dilemma. Experiments using overt and concealed administration of opioids have demonstrated the benefits of a concealed reduction to eliminate negative expectations and prolong analgesic benefits. This may allow for opioid tapering without significant increases in pain. Based on this, we investigated patient and provider acceptance of a concealed opioid reduction for chronic pain.

Methods

We conducted a cross-sectional survey via REDcap with 74 patients, who are currently taking or have taken high dose opioids, and 49 providers using a validated questionnaire based on two hypothetical clinical trials comparing a patient preauthorized concealed opioid reduction vs standard tapering.

SUBMITTER: Bedford T 

PROVIDER: S-EPMC10061052 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature